Cystatin C is associated with adverse COVID-19 outcomes in diverse populations

Kleeman, S. O., Cordioli, M., Timmers, P. R. H. J., Khan, A., Tober-Lau, P., Kurth, F., Demichev, V., Meyer, H. V., Wilson, J. F., Ralser, M., Kiryluk, K., Ganna, A., Baillie, K., & Janowitz, T. (2022). Cystatin C is associated with adverse COVID-19 outcomes in diverse populations. IScience, 25(10), 105040. https://doi.org/10.1016/j.isci.2022.105040
Authors:
Sam O. Kleeman
Mattia Cordioli
Paul R.H. J. Timmers
Atlas Khan
Pinkus Tober-Lau
Florian Kurth
Vadim Demichev
Hannah V. Meyer
James F. Wilson
Markus Ralser
Krzysztof Kiryluk
Andrea Ganna
Kenneth Baillie
Tobias Janowitz
Affiliated Authors:
Atlas Khan
Krzysztof Kiryluk
Author Keywords:
virology
human metabolism
Publication Type:
Article
Unique ID:
10.1016/j.isci.2022.105040
Journal:
Publication Date:
Data Source:
Scopus

Record Created: